By Josh White
Date: Tuesday 05 May 2026
(Sharecast News) - Pfizer reported stronger-than-expected first-quarter results on Tuesday and reaffirmed its full-year guidance, as growth from older blockbusters and recently launched or acquired medicines offset another sharp fall in Covid product sales.
| Patent Woes Threaten Drug Firms | 07-Mar-2011 | New York Times |
| Stocks push higher on deals and strong earnings | 09-Feb-2011 | USA Today |
| Dow soars to close above 12,000 | 02-Feb-2011 | Wall Street Journal |
| Pfizer To Close UK Plant And Axe 2,400 Jobs | 01-Feb-2011 | Sky News |
| Despite good earnings reports, stocks tumble | 21-Oct-2009 | Wall Street Journal |
| Currency | US Dollars |
| Share Price | $ 28.57 |
| Change Today | $ 0.60 |
| % Change | 2.15 % |
| 52 Week High | $28.58 |
| 52 Week Low | $27.84 |
| Volume | 55,646 |
| Shares Issued | 5,686m |
| Market Cap | $162,449m |
| RiskGrade | 102 |
| Strong Buy | 3 |
| Buy | 4 |
| Neutral | 15 |
| Sell | 0 |
| Strong Sell | 1 |
| Total | 23 |

You are here: research